Literature DB >> 4772033

Creatinine: a precursor of methylguanidine.

G Perez, R Faluotico.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4772033     DOI: 10.1007/bf01943863

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

1.  Creatinine excretion in renal failure.

Authors:  R GOLDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

2.  Implication of creatinine and gut flora in the uremic syndrome: induction of "creatininase" in colon contents of the rat by dietary creatinine.

Authors:  J D Jones; P C Burnett
Journal:  Clin Chem       Date:  1972-03       Impact factor: 8.327

3.  Uraemia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine.

Authors:  S Giovannetti; M Biagini; P L Balestri; R Navalesi; P Giagnoni; A De Matteis; P Ferro-Milone; C Perfetti
Journal:  Clin Sci       Date:  1969-06       Impact factor: 6.124

4.  The conversion of creatinine by creatininase of bacterial origin.

Authors:  H G Eyk; R J Vermaat; H J Leijnse-Ybema; B Leijnse
Journal:  Enzymologia       Date:  1968-03

5.  Serum levels and urinary excretion of methylguanidine in chronic renal failure.

Authors:  I M Stein; G Perez; R Johnson; N B Cummings
Journal:  J Lab Clin Med       Date:  1971-06
  5 in total
  2 in total

Review 1.  Clinico-biochemical aspects of guanidine compounds in uraemic toxicity.

Authors:  B K Kishore; Z Kállay; P M Tulkens
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

2.  Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.

Authors:  Manida Suksawat; Jutarop Phetcharaburanin; Poramate Klanrit; Nisana Namwat; Narong Khuntikeo; Attapon Titapun; Apiwat Jarearnrat; Vanlakhone Vilayhong; Prakasit Sa-Ngiamwibool; Anchalee Techasen; Arporn Wangwiwatsin; Panupong Mahalapbutr; Jia V Li; Watcharin Loilome
Journal:  Front Public Health       Date:  2022-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.